1. Home
  2. PACB vs GNE Comparison

PACB vs GNE Comparison

Compare PACB & GNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • GNE
  • Stock Information
  • Founded
  • PACB 2000
  • GNE 2011
  • Country
  • PACB United States
  • GNE United States
  • Employees
  • PACB N/A
  • GNE N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • GNE Power Generation
  • Sector
  • PACB Industrials
  • GNE Utilities
  • Exchange
  • PACB Nasdaq
  • GNE Nasdaq
  • Market Cap
  • PACB 369.5M
  • GNE 407.6M
  • IPO Year
  • PACB 2010
  • GNE N/A
  • Fundamental
  • Price
  • PACB $1.94
  • GNE $14.74
  • Analyst Decision
  • PACB Buy
  • GNE
  • Analyst Count
  • PACB 7
  • GNE 0
  • Target Price
  • PACB $1.90
  • GNE N/A
  • AVG Volume (30 Days)
  • PACB 9.7M
  • GNE 94.4K
  • Earning Date
  • PACB 11-05-2025
  • GNE 11-03-2025
  • Dividend Yield
  • PACB N/A
  • GNE 2.01%
  • EPS Growth
  • PACB N/A
  • GNE 4.51
  • EPS
  • PACB N/A
  • GNE 0.31
  • Revenue
  • PACB $156,110,000.00
  • GNE $456,876,000.00
  • Revenue This Year
  • PACB $6.06
  • GNE $14.60
  • Revenue Next Year
  • PACB $15.15
  • GNE $8.64
  • P/E Ratio
  • PACB N/A
  • GNE $36.66
  • Revenue Growth
  • PACB N/A
  • GNE 3.75
  • 52 Week Low
  • PACB $0.85
  • GNE $13.05
  • 52 Week High
  • PACB $2.72
  • GNE $28.47
  • Technical
  • Relative Strength Index (RSI)
  • PACB 60.27
  • GNE 37.63
  • Support Level
  • PACB $1.93
  • GNE $15.09
  • Resistance Level
  • PACB $2.01
  • GNE $15.76
  • Average True Range (ATR)
  • PACB 0.15
  • GNE 0.47
  • MACD
  • PACB 0.02
  • GNE -0.06
  • Stochastic Oscillator
  • PACB 73.24
  • GNE 0.65

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About GNE Genie Energy Ltd. Class B Stock

Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.

Share on Social Networks: